Immusoft
OverviewSuggest Edit
Immusoft is a biotechnology company that is commercializing technology to program the human immune system by modifying the DNA in immune cells. The core components of its Immune System Programming technology were licensed by Immusoft.
| Type | Private | |
| Founded | 2009 | |
| HQ | Seattle, WA, US | Map |
| Website | immusoft.com |
Latest Updates
| Employees (est.) (Jun 2021) | 15 | |
| Cybersecurity rating | B | More |
Key People/Management at Immusoft
Wendell King
Board Member
Matthew Scholz
Founder, Board Member
Sean Ainsworth
Chief Executive Officer
Immusoft Office Locations
Immusoft has an office in Seattle
Seattle, WA, US (HQ)
454 N 34th St
Immusoft Financials and Metrics
Summary Metrics
Founding Date | 2009 |
Immusoft total Funding | $9.4 m |
Immusoft latest funding size | $3.6 m |
Time since last funding | 3 years ago |
Immusoft investors | Founders Fund, Peter Thiel, Tim Draper, FF Science, Breakout Ventures, Westcott LLC, The Thiel Foundation, Technium Partners, 600 Mile Challenge Fund |
Immusoft's latest funding round in January 2018 was reported to be $3.6 m. In total, Immusoft has raised $9.4 m
Immusoft Cybersecurity Score
Immusoft Online and Social Media Presence
110 Twitter followers
Immusoft has 110 Twitter Followers. The number of followers has increased 1.5% month over month and increased 7.8% quarter over quarter
Immusoft's Trends
Immusoft Blogs
May 12, 2020
Immusoft to Present at ASGCT 23rd Annual Meeting
– Two presentations to highlight the transposon-engineered B lymphocytes ISP™ platform for MPS I and enhancement of muscle mass – Seattle, Wash.–(BUSINESS WIRE) –May 12, 2020– Immusoft Corporation, a Seattle-Wash.-based, leading cell therapy company, today announced two upcoming virtual oral present…
February 05, 2020
Immusoft to Present at WORLDSymposium™ 2020
– Dr. McIvor, Chief Development Officer, to present on the Sleeping Beauty-Engineered B Lymphocytes ISP™ platform – Seattle, Wash.–(BUSINESS WIRE) –February 5, 2020– Immusoft Corporation, a Seattle-Wash.-based, leading cell therapy company, today announced that Scott McIvor, Ph.D., Chief Development…
September 10, 2019
Immusoft to Present at the International Conference on Lymphocyte Engineering 2019
Dr. McIvor, Chief Development Officer, to present on the Sleeping Beauty-Engineered B Lymphocytes ISP™ platform
The post Immusoft to Present at the International Conference on Lymphocyte Engineering 2019 appeared first on Immusoft.
July 17, 2019
Immusoft Announces the Appointment of Robert Hayes, Ph.D. as Chief Scientific Officer
Seattle, Wash.–(BUSINESS WIRE) –July17,2019–Immusoft Corporation, a Seattle-Wash.-based, leading cell therapy company, today announced the appointment of Robert Hayes, Ph.D., as Chief Scientific Officer. With nearly two decades of biologics discovery and development experience, Dr. Hayes will lead I…
Immusoft Frequently Asked Questions
When was Immusoft founded?
Immusoft was founded in 2009.
Who are Immusoft key executives?
Immusoft's key executives are Wendell King, Matthew Scholz and Sean Ainsworth.
How many employees does Immusoft have?
Immusoft has 15 employees.
Who are Immusoft competitors?
Competitors of Immusoft include Singular Genomics, GeneDx and Igenomix.
Where is Immusoft headquarters?
Immusoft headquarters is located at 454 N 34th St, Seattle.
Where are Immusoft offices?
Immusoft has an office in Seattle.
How many offices does Immusoft have?
Immusoft has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies